Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo

[Image: see text] The broad-spectrum DNA alkylating therapeutic, chlorambucil (CBL), has limited safety and shows lower therapy effect because of a short half-life while used in the clinic. Therefore, it is very necessary to develop a more efficient and safer type of CBL derivate against tumors with...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Li, Kang, Dali, Wan, Dan, Chu, Chu, Chen, Meizi, Zhang, Shuihan, Li, Xiong, He, Leye, Yan, Jianye, Liu, Teng, Peng, Yongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424726/
https://www.ncbi.nlm.nih.gov/pubmed/32803080
http://dx.doi.org/10.1021/acsomega.0c02832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424726/
https://www.ncbi.nlm.nih.gov/pubmed/32803080
http://dx.doi.org/10.1021/acsomega.0c02832

Ejemplares similares